Locking Cap keeps medicines secure

Published: 27-Sep-2011
Packaging Regulatory

Features a four-digit combination lock and fits on standard medicine bottles


An innovative device developed by US firm Cap-N-Lock allows prescription drugs to be stored safely in a small, convenient and portable container.

The Locking Cap features a four-digit combination locking mechanism that works with standard medicine bottles and sturdy PVC construction.

The Lincoln, California-based firm says it is easy to use, but virtually impossible to get past without detection, helping to prevent unauthorised and undetected use of drugs for non-medical purposes.

‘The Locking Cap is very easy to operate,’ said Joseph Simpson, president and product designer for Cap-N-Lock. ‘It protects families by blocking access to curious children and experimental teenagers. Plus, it features a compact design that allows for easy access and storage when travelling and at home.’

  • Companies:
  • Cap-N-Lock
See more

You may also like

Packaging

How robots enhance the efficiency of pharmaceutical labelling

Read more
At ACHEMA 2024 (Hall 4.1, Stand B20), HERMA will demonstrate how robotics make challenging labelling processes more reliable, more cost-efficient and faster

Trending Articles

  1. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  2. How robots enhance the efficiency of pharmaceutical labelling At ACHEMA 2024 (Hall 4.1, Stand B20), HERMA will demonstrate how robotics make challenging labelling processes more reliable, more cost-efficient and faster
  3. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  4. Momentum in the US cannabidiol market gains retailers' attention Walmart and other big-name stores in talks with food and drinks makers in preparation for the day CBD-enriched products are allowed on the shelves
  5. Ametek Mocon achieves accreditation for analytical testing laboratory Ametek Mocon, provider of instruments and services for testing, measuring and analysing a variety of gases, has achieved ISO/IEC 17025 accreditation for its Minneapolis analytical testing laboratory

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Packaging

How robots enhance the efficiency of pharmaceutical labelling

At ACHEMA 2024 (Hall 4.1, Stand B20), HERMA will demonstrate how robotics make challenging labelling processes more reliable, more cost-efficient and faster
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Regulatory

Isospec Analytics launches biomolecular analysis technology to identify unknown molecules

The novel technology optimises the identification process of unknown molecules compared to mass analysis
Regulatory

4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA

The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
Subscribe now